tenofovir has been researched along with 1-anilino-8-naphthalenesulfonate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Buti, M; Crans, G; Flaherty, J; Flisiak, R; Gaggar, A; Gane, E; Janssen, HLA; Jump, B; Kaita, K; Kitrinos, K; Manns, M; Marcellin, P; Op den Brouw, M; Wong, DK | 1 |
Cattaneo, D; Filice, C; Gervasoni, C; Riva, A | 1 |
1 trial(s) available for tenofovir and 1-anilino-8-naphthalenesulfonate
Article | Year |
---|---|
Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials.
Topics: Adult; Alanine Transaminase; DNA, Viral; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lipase; Liver; Male; Middle Aged; Nucleotides; Reverse Transcriptase Inhibitors; Symptom Flare Up; Tenofovir; Withholding Treatment | 2019 |
1 other study(ies) available for tenofovir and 1-anilino-8-naphthalenesulfonate
Article | Year |
---|---|
Bictegravir/emtricitabine/tenofovir alafenamide-induced acute pancreatitis: a case report.
Topics: Acute Disease; Adenine; Adult; Alanine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Combinations; Drug Therapy, Combination; Emtricitabine; Heterocyclic Compounds, 4 or More Rings; HIV Infections; Humans; Lipase; Male; Pancreas; Pancreatitis; Piperazines; Pyridones; Tenofovir; Ultrasonography | 2020 |